FDA Strikes Another Blow Against Compounded Medicines: Peptides Rejected at Latest PCAC Meeting
On Wednesday, we witnessed a faceless FDA committee preempted a ban on yet another group of compounded peptides, including the immune modulating, anti-cancer peptide thymosin alpha-1. The FDA’s unjustified decision threatens patients, families, and the promise of personalized medicine. We must act now to protect access to these life-changing treatments. Action Alert! Listen to the […]